Tone mix
Week by week 51 weeks
Share of Arrowhead Research Corporation's 124 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Feb 2, 2026 · tone -100Arrowhead Pharmaceuticals (NASDAQ:ARWR) Posts Earnings Results, Misses Estimates By $0.38 EPS-114
- Week of May 5, 2025 · tone +100Why Arrowhead Pharmaceuticals, Inc. (ARWR) is Among the Best Small Cap Stocks to Buy with the Biggest Upside Potential+100
- Week of Jan 12, 2026 · tone +100Arrowhead Pharmaceuticals (NASDAQ:ARWR) Earns Overweight Rating from Piper Sandler+80
- Week of Jul 28, 2025 · tone +100Arrowhead Pharmaceuticals, Inc. (ARWR) Secures $100M Milestone from Sarepta in RNAi Breakthrough Deal+80
- Week of Jul 21, 2025 · tone -99Arrowhead Pharma (ARWR) Shares Dragged by Sarepta Concerns-75
- Week of Feb 16, 2026 · tone +100Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Given Consensus Recommendation of "Moderate Buy" by Analysts+74
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Arrowhead Research Corporation in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 2 | 0 |
| Last 30 sessions | 5 | +40 |
| Last 90 sessions | 32 | +27 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Monday, October 26, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletArrowhead Pharmaceuticals (NASDAQ:ARWR) and CRISPR Therapeutics (NASDAQ:CRSP) Financial ReviewNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Arrowhead Pharmaceuticals (NASDAQ:ARWR) and CRISPR Therapeutics (NASDAQ:CRSP) Financial Review | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 21, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletHead-To-Head Review: DBV Technologies (NASDAQ:DBVT) vs. Arrowhead Pharmaceuticals (NASDAQ:ARWR)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head-To-Head Review: DBV Technologies (NASDAQ:DBVT) vs. Arrowhead Pharmaceuticals (NASDAQ:ARWR) | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
3 headlines, average tone +67: 2 positive, 1 neutral and 0 negative. Showing all 3.
- www.tickerreport.com · 1 outletArrowhead Pharmaceuticals (NASDAQ:ARWR) Upgraded to "Strong-Buy" at UBS GroupPositive
- www.themarketsdaily.com · 1 outletUBS Group Upgrades Arrowhead Pharmaceuticals (NASDAQ:ARWR) to "Strong-Buy"Positive
- www.themarketsdaily.com · 1 outletArrowhead Pharmaceuticals (NASDAQ:ARWR) versus Sera Prognostics (NASDAQ:SERA) Head to Head ReviewNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Arrowhead Pharmaceuticals (NASDAQ:ARWR) Upgraded to "Strong-Buy" at UBS Group | www.tickerreport.com | 1 | Positive |
| UBS Group Upgrades Arrowhead Pharmaceuticals (NASDAQ:ARWR) to "Strong-Buy" | www.themarketsdaily.com | 1 | Positive |
| Arrowhead Pharmaceuticals (NASDAQ:ARWR) versus Sera Prognostics (NASDAQ:SERA) Head to Head Review | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, September 11, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletArrowhead Pharmaceuticals (NASDAQ:ARWR) Research Coverage Started at CitigroupNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Arrowhead Pharmaceuticals (NASDAQ:ARWR) Research Coverage Started at Citigroup | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, September 8, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletNuvation Bio (NYSE:NUVB) versus Arrowhead Pharmaceuticals (NASDAQ:ARWR) Financial SurveyNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Nuvation Bio (NYSE:NUVB) versus Arrowhead Pharmaceuticals (NASDAQ:ARWR) Financial Survey | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Arrowhead Research Corporation, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.